Viewing Study NCT06918132

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:40 PM
Ignite Modification Date: 2025-12-29 @ 11:30 PM
Study NCT ID: NCT06918132
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-03-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Non-Small Cell Carcinoma View
None Stage IB Lung Cancer AJCC v8 View
None Stage II Lung Cancer AJCC v8 View
None Stage III Lung Cancer AJCC v8 View
None Stage IIIA Lung Cancer AJCC v8 View
None Stage IIIB Lung Cancer AJCC v8 View
Keywords: